Injectafer denied as not medically necessary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies Injectafer for Medical Necessity — and How to Build a Winning Appeal

Injectafer (ferric carboxymaltose) is an intravenous iron replacement therapy used when oral iron is insufficient or not tolerated. BlueCross BlueShield medical-necessity denials for Injectafer typically occur when the plan's reviewer determines that the submitted documentation does not establish that IV iron is required rather than oral iron, or that the clinical criteria specified in BCBS's coverage policy have not been adequately documented. This is one of the most winnable denial categories when the right documentation is assembled.

## Why This Denial Is Appealable

Medical-necessity denials are based on the information the plan had at the time of the initial determination — they are not final clinical judgments. The appeal process exists precisely to allow the prescribing clinician to provide additional documentation that fills any perceived gaps. BCBS must apply "generally accepted standards of medical practice" in its coverage determinations; if your physician's clinical judgment and chart documentation are consistent with those standards (including applicable hematology, gastroenterology, or nephrology society guidelines), the denial is overturned on appeal at a high rate. The key is matching every requirement in BCBS's published policy with a specific, dated chart entry.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 or ACA §2719. You have the right to a full-and-fair review; the plan must provide you the specific clinical criteria it used and all documents it relied upon. Request these in writing.
• External review: If the internal appeal is denied, file for Independent Review Organization (IRO) review within the approximately four-month window specified on your denial letter.
• Expedited review: If the patient's clinical condition is acute or deteriorating, request expedited processing at every level.

## Concrete Appeal Steps and Timeline

1. Request the complete BCBS medical-necessity coverage policy for Injectafer/IV iron and the specific clinical criteria used in the denial determination. 2. Have the prescribing physician review the policy and provide a letter directly addressing each criterion. 3. Compile a complete documentation package (see below) and submit the internal appeal by the deadline on the denial letter. 4. If denied internally, file immediately for external IRO review.

## Documentation to Gather

• Diagnosis confirmation: Current lab results (ferritin, transferrin saturation, hemoglobin) and clinical notes confirming iron-deficiency anemia and its underlying cause.
• Prior treatment history: Documented dates, duration, and outcomes of oral iron therapy — including specific adverse effects, malabsorption issues, GI intolerance, or failure to achieve adequate repletion — that establish why oral iron is not appropriate.
• Clinical severity: Physician notes documenting symptom burden (fatigue, dyspnea, functional impairment), comorbidities that affect iron absorption or increase urgency, and the clinical rationale for IV rather than oral replacement.
• Prescriber medical-necessity letter: A letter from the treating physician or specialist explicitly stating why Injectafer is medically necessary for this patient and why alternatives are not appropriate, with reference to the applicable clinical guideline organization.

## Criteria-Mapping Structure

Obtain the exact medical-necessity criteria from BCBS's Injectafer coverage policy. Build a table: left column lists each criterion verbatim; right column cites the specific chart entry, lab result, or physician statement that satisfies it. If any criterion cannot be met, address it directly with clinical context rather than leaving it blank. This structure forces the reviewer to engage with your evidence item by item and is the most effective format for reversing medical-necessity denials.